{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:05:51Z","timestamp":1776125151168,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.biopha.2026.119125","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:28:33Z","timestamp":1772526513000},"page":"119125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Therapeutic antagonism of a key toxin driving Alzheimer\u2019s disease: Comparison of a peptide variant and small molecule"],"prefix":"10.1016","volume":"197","author":[{"given":"Catalina Vigil","family":"Cardenal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9218-6927","authenticated-orcid":false,"given":"Kashif","family":"Mahfooz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1848-4811","authenticated-orcid":false,"given":"Sara","family":"Garcia-Rates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5127-084X","authenticated-orcid":false,"given":"Sibah","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Greenfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119125_bib1","doi-asserted-by":"crossref","first-page":"S611","DOI":"10.3233\/JAD-179935","article-title":"Role of amyloid-\u03b2 and Tau proteins in Alzheimer\u2019s disease: confuting the amyloid cascade","volume":"64","author":"Gulisano","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2026.119125_bib2","doi-asserted-by":"crossref","unstructured":"Greenfield S. Discovering and targeting the basic mechanism of neurodegeneration: The role of peptides from the C-terminus of acetylcholinesterase: Non-hydrolytic effects of ache: The actions of peptides derived from the C-terminal and their relevance to neurodegeneration 2013. https:\/\/doi.org\/10.1016\/j.cbi.2013.03.015.","DOI":"10.1016\/j.cbi.2013.03.015"},{"key":"10.1016\/j.biopha.2026.119125_bib3","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1002\/alz.13869","article-title":"Evidence for a novel neuronal mechanism driving Alzheimer\u2019s disease, upstream of amyloid","volume":"20","author":"Garcia Rat\u00e9s","year":"2024","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.biopha.2026.119125_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2022.106260","article-title":"When a trophic process turns toxic: Alzheimer\u2019s disease as an aberrant recapitulation of a developmental mechanism","volume":"149","author":"Garcia-Rat\u00e9s","year":"2022","journal-title":"Int J. Biochem Cell Biol."},{"key":"10.1016\/j.biopha.2026.119125_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312837","article-title":"A novel 14mer peptide inhibits autophagic flux via selective activation of the mTORC1 signalling pathway: implications for Alzheimer\u2019s disease","volume":"25","author":"Garc\u00eda Porta","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119125_bib6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.neuropharm.2016.02.006","article-title":"I) Pharmacological profiling of a novel modulator of the \u03b17 nicotinic receptor: blockade of a toxic acetylcholinesterase-derived peptide increased in Alzheimer brains","volume":"105","author":"Garcia-Rat\u00e9s","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2026.119125_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-024-04079-7","article-title":"A novel peptide driving neurodegeneration appears exclusively linked to the \u03b17 nicotinic acetylcholine receptor","author":"Ranglani","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2026.119125_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1471-4159.2004.02494.x","article-title":"A novel peptide modulates \u03b17 nicotinic receptor responses: implications for a possible trophic-toxic mechanism within the brain","volume":"90","author":"Greenfield","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2026.119125_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115498","article-title":"Antagonism of a key peptide \u201cT14\u201d driving neurodegeneration: evaluation of a next generation therapeutic","volume":"167","author":"Ranglani","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119125_bib10","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.biopha.2018.10.124","article-title":"Protective and reversal actions of a novel peptidomimetic against a pivotal toxin implicated in Alzheimer\u2019s disease","volume":"109","author":"Ferrati","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119125_bib11","article-title":"A novel process driving Alzheimer\u2019s disease validated in a mouse model: therapeutic potential","volume":"8","author":"Greenfield","year":"2022","journal-title":"Alzheimer\u2019S. Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.biopha.2026.119125_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0097-y","article-title":"Control of protein degradation by N-terminal acetylation and the N-end rule pathway","volume":"50","author":"Nguyen","year":"2018","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.biopha.2026.119125_bib13","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.bbamem.2017.06.002","article-title":"Probing the disparate effects of arginine and lysine residues on antimicrobial peptide\/bilayer association","volume":"1859","author":"Rice","year":"2017","journal-title":"Biochim. Et. Biophys. Acta (BBA) Biomembr."},{"key":"10.1016\/j.biopha.2026.119125_bib14","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.bbamem.2012.06.006","article-title":"Cell surface binding and uptake of arginine- and lysine-rich penetratin peptides in absence and presence of proteoglycans","volume":"1818","author":"\u00c5mand","year":"2012","journal-title":"Biochim. Et. Biophys. Acta (BBA) Biomembr."},{"key":"10.1016\/j.biopha.2026.119125_bib15","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/pro.3698","article-title":"Methionine in proteins: The Cinderella of the proteinogenic amino acids","volume":"28","author":"Aledo","year":"2019","journal-title":"Protein Sci."},{"key":"10.1016\/j.biopha.2026.119125_bib16","doi-asserted-by":"crossref","unstructured":"Brai E., Stuart S., Badin A.-S., Greenfield S.A., Parlato R., Pereira C.F. A Novel Ex Vivo Model to Investigate the Underlying Mechanisms in Alzheimer\u2019s Disease, 2017. https:\/\/doi.org\/10.3389\/fncel.2017.00291.","DOI":"10.3389\/fncel.2017.00291"},{"key":"10.1016\/j.biopha.2026.119125_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.838594","article-title":"Modeling the human brain with ex vivo slices and in vitro organoids for translational neuroscience","volume":"16","author":"Nogueira","year":"2022","journal-title":"Front Neurosci."},{"key":"10.1016\/j.biopha.2026.119125_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-39808-w","article-title":"Spatio-temporal activation patterns of neuronal population evoked by optostimulation and the comparison to electrical microstimulation","volume":"13","author":"Margalit","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119125_bib19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00018-024-05374-1","article-title":"Novel interplay between agonist and calcium binding sites modulates drug potentiation of \u03b17 acetylcholine receptor","volume":"81","author":"Mukhtasimova","year":"2024","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2026.119125_bib20","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1089\/ars.2018.7506","article-title":"Dysregulation of intracellular calcium signaling in Alzheimer\u2019s disease","volume":"29","author":"Popugaeva","year":"2018","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2026.119125_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.neuropharm.2016.02.006","article-title":"I) Pharmacological profiling of a novel modulator of the \u03b17 nicotinic receptor: blockade of a toxic acetylcholinesterase-derived peptide increased in Alzheimer brains","volume":"105","author":"Garcia-Rat\u00e9s","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2026.119125_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040958","article-title":"PC12 cell line: cell types, coating of culture vessels, differentiation and other culture conditions","volume":"9","author":"Wiatrak","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119125_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/neu.10109","article-title":"Desensitization of neuronal nicotinic receptors","volume":"53","author":"Quick","year":"2002","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.biopha.2026.119125_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115498","article-title":"Antagonism of a key peptide \u201cT14\u201d driving neurodegeneration: evaluation of a next generation therapeutic","volume":"167","author":"Ranglani","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119125_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13695","article-title":"Complex in vitro model: a transformative model in drug development and precision medicine","volume":"17","author":"Wang","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.biopha.2026.119125_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4014\/jmb.1508.08007","article-title":"Cell-based assay design for high-content screening of drug candidates","volume":"26","author":"Nierode","year":"2016","journal-title":"J. Microbiol Biotechnol."},{"key":"10.1016\/j.biopha.2026.119125_bib27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cbpa.2004.04.002","article-title":"Complex phenotypic assays in high-throughput screening","volume":"8","author":"Clemons","year":"2004","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.biopha.2026.119125_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-61779-536-7_18","article-title":"Use of PC12 cells and rat superior cervical ganglion sympathetic neurons as models for neuroprotective assays relevant to Parkinson\u2019s disease","volume":"846","author":"Grau","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2026.119125_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.1016559","article-title":"The cellular model for Alzheimer\u2019s disease research: PC12 cells","volume":"15","author":"Xie","year":"2023","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.biopha.2026.119125_bib30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fcell.2020.00328","article-title":"In vitro models of neurodegenerative diseases","volume":"8","author":"Slanzi","year":"2020","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119125_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114120","article-title":"Antagonising a novel toxin \u201cT14\u201d in Alzheimer\u2019s disease: comparison of receptor blocker versus antibody effects in vitro","volume":"158","author":"Hasan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119125_bib32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/biom11030343","article-title":"Optimizing calcium detection methods in animal systems: a sandbox for synthetic biology","volume":"11","author":"Li","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2026.119125_bib33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainresbull.2012.11.003","article-title":"\u03b17 Nicotinic acetylcholine receptors and their role in cognition","volume":"93","author":"Lendvai","year":"2013","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2026.119125_bib34","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.cell.2021.02.049","article-title":"Structure and gating mechanism of the \u03b17 nicotinic acetylcholine receptor","volume":"184","author":"Noviello","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119125_bib35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.21037\/atm-21-273","article-title":"Cellular responses and functions of \u03b17 nicotinic acetylcholine receptor activation in the brain: a narrative review","volume":"9","author":"Xu","year":"2021","journal-title":"Ann. Transl. Med"},{"key":"10.1016\/j.biopha.2026.119125_bib36","doi-asserted-by":"crossref","first-page":"13119","DOI":"10.3390\/ijms232113119","article-title":"Characterization of a bioactive peptide T14 in the human and rodent substantia nigra: implications for neurodegenerative disease","volume":"23","author":"Greenfield","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119125_bib37","doi-asserted-by":"crossref","unstructured":"Peter Guengerich F. Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development. Drug Metab Pharmacokinet, 2010;26:3. https:\/\/doi.org\/10.2133\/DMPK.DMPK-10-RV-062.","DOI":"10.2133\/dmpk.DMPK-10-RV-062"},{"key":"10.1016\/j.biopha.2026.119125_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-022-01207-x","article-title":"Drug toxicity assessment: cell proliferation versus cell death","volume":"8","author":"Sazonova","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biopha.2026.119125_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2021.119061","article-title":"Cell death as a result of calcium signaling modulation: a cancer-centric prospective","volume":"1868","author":"Danese","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Cell Res."},{"key":"10.1016\/j.biopha.2026.119125_bib40","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1002\/alz.13869","article-title":"Evidence for a novel neuronal mechanism driving Alzheimer\u2019s disease, upstream of amyloid","volume":"20","author":"Garcia Rat\u00e9s","year":"2024","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.biopha.2026.119125_bib41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/neu.10109","article-title":"Desensitization of neuronal nicotinic receptors","volume":"53","author":"Quick","year":"2002","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.biopha.2026.119125_bib42","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/cne.902300211","article-title":"Ultrastructural localization of acetylcholinesterase in substantia nigra: A comparison between rat and guinea pig","volume":"230","author":"Henderson","year":"1984","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.biopha.2026.119125_bib43","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0161-5890(01)00108-0","article-title":"Calcium and oxidative stress: from cell signaling to cell death","volume":"38","author":"Ermak","year":"2002","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biopha.2026.119125_bib44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrd.2018.26","article-title":"Impact of target interactions on small-molecule drug disposition: an overlooked area","volume":"17","author":"Van Waterschoot","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2026.119125_bib45","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2022.02.011","article-title":"Challenges in delivering therapeutic peptides and proteins: a silk-based solution","volume":"345","author":"Wu","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2026.119125_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100075","article-title":"Biologics vs. small molecules: drug costs and patient access","volume":"9","author":"Makurvet","year":"2021","journal-title":"Med Drug Discov."},{"key":"10.1016\/j.biopha.2026.119125_bib47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/jcp.55.2.158-a","article-title":"Brain drug targeting: the future of brain drug development. Pardridge W M. Cambridge University Press, 2001, \u00a365.00. ISBN 0 521 80077 3","volume":"55","author":"Kamphorst","year":"2002","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.biopha.2026.119125_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2024.101760","article-title":"The penetration of therapeutics across the blood-brain barrier: classic case studies and clinical implications","author":"Banks","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.biopha.2026.119125_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph13110394","article-title":"Treatment of alzheimer\u2019s disease and blood\u2013brain barrier drug delivery","volume":"13","author":"Pardridge","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2026.119125_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ph15101283","article-title":"Strategies for improving peptide stability and delivery","volume":"15","author":"Al Musaimi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2026.119125_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092714","article-title":"Peptides as therapeutic agents for inflammatory-related diseases","volume":"19","author":"La Manna","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119125_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2021.01.015","article-title":"Replacement of L-amino acid peptides with D-amino acid peptides mitigates anti-PEG antibody generation against polymer-peptide conjugates in mice","volume":"331","author":"Sylvestre","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119125_bib53","first-page":"1","article-title":"Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines","volume":"10","author":"Xiao","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119125_bib54","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2026.119125_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1019412","article-title":"Small-molecule drugs development for Alzheimer\u2019s disease","volume":"14","author":"Yao","year":"2022","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.biopha.2026.119125_bib56","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1177\/0271678X20985946","article-title":"Understanding the brain uptake and permeability of small molecules through the BBB: a technical overview","volume":"41","author":"Chowdhury","year":"2021","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.biopha.2026.119125_bib57","first-page":"853","article-title":"Paving the way for small-molecule drug discovery","volume":"13","author":"Ma","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.biopha.2026.119125_bib58","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jmb.2011.12.026","article-title":"Modulating protein\u2013protein interactions with small molecules: the importance of binding hotspots","volume":"415","author":"Thangudu","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.biopha.2026.119125_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw8412","article-title":"Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials","volume":"11","author":"Lin","year":"2019","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.biopha.2026.119125_bib60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119125_bib61","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.drudis.2021.09.017","article-title":"Designing small molecules for therapeutic success: a contemporary perspective","volume":"27","author":"Maurer","year":"2022","journal-title":"Drug Discov. Today"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:18:10Z","timestamp":1776122290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226001575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":61,"alternative-id":["S0753332226001575"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119125","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic antagonism of a key toxin driving Alzheimer\u2019s disease: Comparison of a peptide variant and small molecule","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119125"}}